| Views | |
|---|---|
| A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 332 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 1 | 12 | 3 | 2 | 4 | 12 | 21 |
| Views | |
|---|---|
| 2019_Denker_etal.pdf | 155 |
